Showing results (371-380 of 444) with videos related to

Sort By:
Pageof 45
Multidisciplinary Respiratory Medicine|August 5, 2025
Perception of the role of Telemedicine in Interstitial Lung Diseases: -Findings from Società Italiana di Pneumologia/ Italian Respiratory -Society (SIP-IRS) surveyGiorgio Monteleone, Gioele Castelli, Giovanni Franco, et al.
Lung|July 8, 2025
Effectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter StudyMichele Mondoni, Francesco Varone, Fabrizio Luppi, et al.
Respirology (Carlton, Vic.)|November 2, 2011
A disintegrin and metalloprotease (ADAM) 33 protein in patients with pulmonary sarcoidosisAsif Shaffiq, Hans Michael Haitchi, Yun Yung Pang, et al.
Scientific Reports|October 17, 2019
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation GenesNancy Casanova, Tong Zhou, Manuel L Gonzalez-Garay, et al.
Scientific Reports|January 23, 2016
Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease ProbesNimali P Withana, Xiaowei Ma, Helen M McGuire, et al.
Biomedicines|July 27, 2024
Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative ReviewHelena Buso, Claudia Discardi, Patrick Bez, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
The Lancet. Respiratory Medicine|November 21, 2017
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White PaperDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
Chest|March 26, 2009
Performance of tests for latent tuberculosis in different groups of immunocompromised patientsLuca Richeldi, Monica Losi, Roberto D'Amico, et al.
JAMA|May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical TrialGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
Pageof 45